We are no longer recruiting
volunteers for this particular study. Please call our office at
(860) 443-4567, for information about similar upcoming clinical
research studies
Clinical Trial for Women
who Experience Sexual Dysfunction
Following Hysterectomy with
Removal of the Ovaries
Who
should participate:
This
study is for women who remain sexually active after hysterectomy despite
experiencing a decrease in sexual desire, arousal or satisfaction.
Testosterone is a natural hormone produced in both men and women, and it is
thought to play a role in normal sexual function. The ovaries are a major
source of testosterone in women, and testosterone levels decline with
removal of the ovaries. This study is for women who feel that their
decreased sexual interest, arousal or satisfaction has developed as a result
of hysterectomy with removal of their ovaries.
Study Medication:
Ø
This is a
study of an investigational gel form of testosterone which is applied to the
skin.
Basic Eligibility Requirements:
Ø
Age 30-65
Ø
Previous
hysterectomy and removal of both ovaries.
Ø
Experiencing
decreased sexual desire (libido) or arousal, with difficulty achieving
orgasm.
Ø
Must be
sexually active at least once a month, even if the sexual activity may not
be fully satisfying.
Ø
Certain
medications used currently or in the past may exclude participation in this
trial.
Testing is performed at Coastal
Connecticut
Research offices and is provided at no charge. We are happy to share
test results with your primary physician:
Ø
EKG
Ø
lab work and
physical exam
Duration of study:
Ø
7 visits over
20 weeks, starting with the baseline visit when medication is first given.
Compensation:
Ø
Participants
will receive $25 per visit, beginning with the baseline visit when
medication is first given. On two visits subjects will be required to stay
at the Coastal Connecticut Research office for 6 hours, and compensation for
those visits will be $100 each. With successful completion of the study this
totals $325 for 7 visits.
Confidentiality:
All
information collected from patients is kept strictly private. While all
study information from participating women will be made available to the
sponsor of this study and to the FDA, in all but rare cases (for example, an
audit or investigation) your identity will remain unknown to them and to
others connected with this study. We are happy to share all test results
with your primary physician.
Please note:
The
preceding is an overview of this clinical trial and is intended to provide
prospective patients with information that may help them decide whether to
consider participating in the trial. There are additional details regarding
inclusion/exclusion criteria, and details
important to making a final decision regarding participation that are not
listed on this page. These will be discussed with interested participants in
person by a member of Coastal Connecticut Research, and all relevant
information will be provided in the Informed Consent Form that must be
reviewed by the prospective participant.
We
hope that you will consider joining us at Coastal Connecticut Research in
this research trial. Together we can help develop new solutions for problems
faced by today’s active women.